Managing Multiple Sclerosis and Crohn's Disease: Current Treatments and Individualized Care

There is currently no cure for multiple sclerosis (MS) or Crohn's disease, but both are manageable with therapies that control symptoms, slow progression, and improve quality of life. Treatment is highly individualized.

Multiple Sclerosis (MS) Management

Disease-Modifying Therapies (DMTs)

DMTs reduce relapse frequency, slow disability accumulation, and limit new CNS lesions. Options include:

• Injectables: Interferon beta, glatiramer acetate
• Oral agents: Fingolimod, dimethyl fumarate, teriflunomide, siponimod, cladribine
• Infusion therapies: Natalizumab, ocrelizumab, alemtuzumab, ofatumumab

DMT selection depends on disease activity, risk profile, comorbidities, and patient preference.

Symptom Management

• Physical/occupational therapy for mobility, spasticity, fatigue
• Speech therapy for dysarthria, dysphagia
• Medications for neuropathic pain, bladder/bowel dysfunction, depression, cognitive changes

Crohn's Disease Management

Medication Classes

• Aminosalicylates (5-ASA): Mesalamine—for mild colonic disease
• Corticosteroids: Prednisone, budesonide—for acute flares only (not maintenance)
• Immunomodulators: Azathioprine, 6-mercaptopurine, methotrexate—steroid-sparing maintenance
• Biologics: Anti-TNF (infliximab, adalimumab), anti-integrin (vedolizumab), anti-IL-12/23 (ustekinumab), anti-IL-23 (risankizumab)—for moderate-severe disease
• Small molecules: JAK inhibitors (upadacitinib)

Adjunctive Strategies

• Dietary modification (low-FODMAP, exclusive enteral nutrition for flares)
• Smoking cessation (smoking worsens Crohn's)
• Surgery for strictures, fistulas, abscesses, or refractory disease

Key Principle

Both conditions require ongoing specialist care (neurologist for MS, gastroenterologist for Crohn's) with regular monitoring, treatment adjustment, and multidisciplinary support.